SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman Sobo

NORTHFIELD, Ill., July 01, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today an

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Medline Inc. is rated a buy, driven by robust sector macroeconomics, strong ROE, organic Q1 growth,

NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts bre

Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the pric

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in t

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the pric

Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurg

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensu

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163

Medline (NASDAQ:MDLN) announced a strategic agreement to implement next-generation warehouse automat

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting ear

FDA warns Medline over device quality lapses, citing CAPA failures, contamination risks, and unresol

Groundbreaking is first operational initiative as a publicly traded company on its continued traject

JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and raises the pric

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Blackstone, The Carlyle Group, Hellman and Friedman LLC, and the ADIA, are offering 75 million share

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

Morgan Stanley analyst Patrick Wood maintains Medline (NASDAQ:MDLN) with a Overweight and raises

Wells Fargo analyst Stephen Baxter maintains Medline (NASDAQ:MDLN) with a Equal-Weight and raises

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and raises the pric

UBS analyst Kevin Caliendo maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target

BMO Capital analyst Sean Dodge maintains Medline (NASDAQ:MDLN) with a Outperform and raises the p

RBC Capital analyst Ryan Halsted maintains Medline (NASDAQ:MDLN) with a Outperform and raises the

Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform a

Medline (NASDAQ:MDLN) reported quarterly losses of $(0.01) per share which missed the analyst consen

FDA labels Medline homecare bed instruction update as most serious recall after reports of fires, in

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/electronic-homecare-bed-

Tigress Financial analyst Ivan Feinseth initiates coverage on Medline (NASDAQ:MDLN) with a Buy ra

Private equity giant Blackstone Inc. said that the long-awaited recovery in global dealmaking is now

Jim Cramer recommended selling Super Micro Computer Inc. and doesn't recommend Alkermes plc. Hun

Medline received favorable coverage from several analysts. It recently raised $7 billion in an IPO a

Stifel analyst Rick Wise initiates coverage on Medline (NASDAQ:MDLN) with a Buy rating and announ

Goldman Sachs analyst David Roman initiates coverage on Medline (NASDAQ:MDLN) with a Buy rating a

Deutsche Bank analyst Pito Chickering initiates coverage on Medline (NASDAQ:MDLN) with a Hold rat